Nuzenio

Tradingview Astrazeneca

Tradingview Astrazeneca entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 16 latest news signals 1 publisher sources 100/100 entity strength

Latest news

Timeline

Fri, 07 Aug 2026 04:20:00 GMTAstraZeneca PLC Stock 12‑Month Price Target Raised to GBX 16091.9, Implies 36% Upside - TradingView
Wed, 05 Aug 2026 13:50:32 GMT'No discussions' over AstraZeneca-Bristol Myers deal, senior source says - TradingView
Mon, 03 Aug 2026 20:29:41 GMTAstraZeneca Stock Plunges 7.7% on Reported $400 Billion Merger Talks - TradingView
Mon, 03 Aug 2026 14:05:00 GMTREG - AstraZeneca PLC - Admission of Further Securities to Trading - TradingView
Mon, 03 Aug 2026 11:33:16 GMTWeekly Recap: AstraZeneca merger talks and NYSE:BMY raises 2026 guidance - TradingView
Mon, 03 Aug 2026 10:13:38 GMTAstraZeneca launches Imjudo cancer drug in China - TradingView

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Tradingview Astrazeneca.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

1 distinct publisher/source names are currently connected to this entity page.